Virtual Reality Versus Intradialytic Neuromuscular Electrical Stimulation on Renin Hormone in Chronic Kidney Patients
CompletedNot applicableNCT07760285
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Worldwide accelerated advances in physical rehabilitation of chronic kidney disease; particularly whom undergoing hemodialysis. Multimodal therapeutic approaches may maximize their recovery through preliminary evidence indicating both intradialytic neuromuscular electrical stimulation or Virtual reality-based rehabilitation (VRBR) is a relatively new method that might make it easier to simulate doing functional tasks than conventional rehabilitation.
Study details
- Official title
- Virtual Reality Versus Intradialytic Neuromuscular Electrical Stimulation On Renin Hormone in Chronic Kidney Disease
- Conditions
- Chronic Kidney Disease (Stages 3b-5)
- Hemodialysis
- Shoulder Adhesive Capsulitis
- Interventions
- Other: Virtual Reality session
- Other: intradialytic neuromuscular electrical stimulation
- Other: Maitland Mobilization
- Other: Conventional Physical Therapy protocol
- Sponsor
- Adly A Adam
- Organization
- Cairo University
- Start date
- 2026-01-01
- Primary completion
- 2026-07-01
- Sex
- All
- Age range
- from 40 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient underwent modified radical mastectomy from one month earlier. * Patients suffering from shoulder pain and limited range of motion were included in current study. * Patients' age ranged from 40 to 65 years. * Patients of both genders. * All patients were free of any comorbidities such as systemic or neurological diseases. Exclusion Criteria: * Patient underwent chemotherapy. * Diabetic patients. * Patient have any comorbidities such as systemic or neurological diseases.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07760285